Heart disease remains the leading cause of death worldwide. The proliferation of heart issues — paired with lifestyle factors that complicate patient recruitment and study design — reflect an urgent need for expert-led clinical trials. Moreover, intersections among heart health and metabolic research offer promising opportunities to confront diseases affecting a growing, aging population, and … Read more
The global prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) is rising. In light of the stark unmet needs in liver disease treatment — particularly for metabolic dysfunction-associated steatohepatitis (MASH) — there’s a pressing need for more sites equipped to effectively support advanced liver disease research. As Kris Kowdley, MD, AGAF, FAASLD, FACP, FACG, mentions … Read more
Velocity recently asked some key employees to come together and discuss a wide array of issues impacting diversity, equity, and inclusion (DEI) in clinical trials. Velocity’s ongoing goals are to share best practices, identify and address shortcomings, and bring as many perspectives and viewpoints to the table as possible to advance clinical trial science and … Read more
Évelyne Newton and Sylwia Kołodziej recently made the journey overseas to join our CARE Council summit in Durham, NC. Along with dozens of our physicians and operational, commercial, and recruitment leaders, they helped define a strategy to extend the reach of new and existing CARE Councils. As they mention in this video, by enhancing the … Read more
Last month, Nick Spittal, Velocity’s chief operating officer announced the company’s latest partnership with HealthMatch and results from an unprecedented patient recruitment pilot at the SCOPE conference in Orland, Florida. He was joined by HealthMatch CEO, Manuri Gunawardena, on stage for a joint presentation, as Clinical Trials Report journalist Michael Causey reports: Velocity announced its … Read more
Despite a boom in tech funding and monumental advancements in AI/ML and in silico models, tech advancements have not yet translated into marked efficiency improvements at clinical research sites. Most clinical trials still fail to meet enrollment timelines, with most delays occurring at the site level. To gain efficiency, technology must enhance clinical trials at … Read more
“[Patient centricity] is about taking those patient insights and their voice and translating them into actions. And that was really the impetus for what we saw in Velocity’s submission.” – Pat Roselle, Global Head of Patient Stakeholder Engagement at Sanofi. Thank you to Pat and Jimmy Bechtel for joining Nick Spittal to discuss the initiatives … Read more
As part of our integrated site infrastructure, Velocity has established specialized laboratory and diagnostic capabilities. This includes purpose-built, CLIA-certified lab facilities at all dedicated sites, as well as in-network PBMC processing at 30+ Velocity locations across the U.S. and Europe. As Nick Spittal, Chief Operations Officer, explains in this video, Velocity is also using these … Read more
About half of Principal Investigators (PIs) conduct only a single study in their career. This high turnover rate results in significant inefficiencies for Sponsors and CROs, particularly when it comes to finding reliable PIs capable of delivering high-quality trial conduct and enrollment in specialized research areas. Velocity developed the innovative Principal Investigator Onboarding and Training (PIVOT) … Read more
To bring equitable products to market, clinical trials need proportionate representation. Reaching the right patients must be prioritized at the site level, where clinical research is most visible in communities. Therefore, Velocity is heavily invested in leveraging the power of local influence to drive change. Our focus is on managing what we can effectively control … Read more
Learn more about Velocity's capabilities
Whether you’re ready to conduct a single-site study or a complex, high-volume trial, Velocity will ensure you have the right investigators, clinical staff, and patients for your research program.
Join a remarkable team doing remarkable work
Velocity careers offer competitive pay and benefits, and reward high performance with excellent opportunities.
Whether you're an industry veteran or are looking to take your first step into clinical research, we invite you to apply at Velocity.